Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Perini, Guilherme Fleury
88  Ergebnisse:
Personensuche X
?
1

Fine and Gray or Cox model?:

Arcuri, Leonardo Javier ; Souza Santos, Fabio Pires de ; Perini, Guilherme Fleury.
Blood Advances.  8 (2024)  6 - p. 1420-1421 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Pembrolizumab in Relapsed or Refractory Primary Mediastinal..:

Zinzani, Pier Luigi ; Thieblemont, Catherine ; Melnichenko, Vladimir...
Blood Journal.  , 2023
Link: https://doi.org/10.1182/..
 
?
3

Quality-of-life analysis of pembrolizumab vs brentuximab ve..:

Zinzani, Pier Luigi ; Ramchandren, Radhakrishnan ; Santoro, Armando...
Blood Advances.  6 (2022)  2 - p. 590-599 , 2022
Link: https://doi.org/10.1182/..
 
?
4

Progressive multifocal leukoencephalopathy in a patient wit..:

Teixeira, Larissa Lane Cardoso ; Nunes, Viviane Regina Hernandez ; Perini, Guilherme Fleury...
Hematology, Transfusion and Cell Therapy.  44 (2022)  3 - p. 437-439 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Baseline total metabolic tumor volume (TMTV) application in..:

Feres, Carolina Cristina Pellegrino ; Nunes, Rafael Fernandes ; Teixeira, Larissa Lane Cardoso..
Clinical and Translational Imaging.  10 (2022)  3 - p. 273-284 , 2022
Link: https://doi.org/10.1007/..
 
?
6

BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leuke..:

Perini, Guilherme Fleury ; Feres, Carolina Cristina Pellegrino ; Teixeira, Larissa Lane Cardoso.
Current Treatment Options in Oncology.  22 (2021)  8 - p. , 2021
Link: https://doi.org/10.1007/..
 
?
7

How to manage lymphoid malignancies during novel 2019 coron..:

Perini, Guilherme Fleury ; Fischer, Thais ; Gaiolla, Rafael Dezen...
Hematology, Transfusion and Cell Therapy.  42 (2020)  2 - p. 103-110 , 2020
Link: https://doi.org/10.1016/..
 
?
8

BCL-2 as therapeutic target for hematological malignancies:

Perini, Guilherme Fleury ; Ribeiro, Glaciano Nogueira ; Pinto Neto, Jorge Vaz..
Journal of Hematology & Oncology.  11 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
9

Everolimus as a single agent in refractory or relapsed Hodg..:

Rocha, Talita Máira Bueno da Silveira da ; Fortier, Sergio Costa ; Fischer, Thais Rodrigues da Cunha...
Revista Brasileira de Hematologia e Hemoterapia.  39 (2017)  3 - p. 216-222 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Imbalance of Pro- and Anti-Inflammatory Cytokines in Patien..:

Brito da Silva, Priscilla ; Perini, Guilherme Fleury ; Andrade Pereira, Luciana de...
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. S151-S157 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Impact of treatment on IL-4, IL-6, IL-10 and sCD25 levels i..:

Silva, Priscilla Brito ; Perini, Guilherme Fleury ; Cavalcante, Egyla M....
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. S222-S223 , 2015
Link: https://doi.org/10.1016/..
 
?
12

Brentuximab Vedotin in CD30+ Lymphomas:

Perini, Guilherme Fleury ; Pro, Barbara
Biologics in Therapy.  3 (2013)  1 - p. 15-23 , 2013
Link: https://doi.org/10.1007/..
 
?
13

Alemtuzumab in the reversal of encephalopathy associated wi..:

Perini, Guilherme Fleury ; Santos, Fábio P. S. ; Hamerschlak, Nelson
British Journal of Haematology.  147 (2009)  5 - p. 592-592 , 2009
Link: https://doi.org/10.1111/..
 
?
14

Lower socioeconomic status is independently associated with..:

Biasoli, Irene ; Castro, Nelson ; Delamain, Marcia...
International Journal of Cancer.  142 (2017)  5 - p. 883-890 , 2017
Link: https://doi.org/10.1002/..
 
?
15

Progressive multifocal leukoencephalopathy in a patient wit..:

Teixeira, Larissa Lane Cardoso ; Nunes, Viviane Regina Hernandez ; Perini, Guilherme Fleury...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477769/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15